{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:14:52Z","timestamp":1780647292153,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Jiangsu Province Capability Improvement Project through Science, Technology and Education","award":["ZDXK202209"],"award-info":[{"award-number":["ZDXK202209"]}]},{"name":"Translational Research Grant of NCRCH","award":["2020ZKZB01"],"award-info":[{"award-number":["2020ZKZB01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00277-024-05631-0","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T13:50:43Z","timestamp":1706190643000},"page":"2257-2266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The clinical significance and prognostic value of serum beta-2 microglobulin in adult lymphoma-associated hemophagocytic lymphohistiocytosis: a multicenter analysis of 326 patients"],"prefix":"10.1007","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8520-7015","authenticated-orcid":false,"given":"Ze","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuzhang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwen","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanchuan","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maozhong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijia","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiurong","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiudan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"issue":"6","key":"5631_CR1","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1084\/jem.138.6.1608","volume":"138","author":"HM Grey","year":"1973","unstructured":"Grey HM, Kubo RT, Colon SM, Poulik MD, Cresswell P, Springer T, Turner M, Strominger JL (1973) The small subunit of HL-A antigens is beta 2-microglobulin. J Exp Med 138(6):1608\u20131612. https:\/\/doi.org\/10.1084\/jem.138.6.1608","journal-title":"J Exp Med"},{"issue":"7","key":"5631_CR2","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1073\/pnas.69.7.1697","volume":"69","author":"PA Peterson","year":"1972","unstructured":"Peterson PA, Cunningham BA, Bergg\u00e5rd I, Edelman GM (1972) 2 -Microglobulin--a free immunoglobulin domain. Proc Natl Acad Sci U S A 69(7):1697\u20131701. https:\/\/doi.org\/10.1073\/pnas.69.7.1697","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1-2","key":"5631_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.drudis.2008.11.001","volume":"14","author":"C Shi","year":"2009","unstructured":"Shi C, Zhu Y, Su Y, Chung LW, Cheng T (2009) Beta2-microglobulin: emerging as a promising cancer therapeutic target. Drug Discov Today 14(1-2):25\u201330. https:\/\/doi.org\/10.1016\/j.drudis.2008.11.001","journal-title":"Drug Discov Today"},{"issue":"3","key":"5631_CR4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.5045\/br.2014.49.3.148","volume":"49","author":"C Yoo","year":"2014","unstructured":"Yoo C, Yoon DH, Suh C (2014) Serum beta-2 microglobulin in malignant lymphomas: an old but powerful prognostic factor. Blood Res 49(3):148\u2013153. https:\/\/doi.org\/10.5045\/br.2014.49.3.148","journal-title":"Blood Res"},{"issue":"1-2","key":"5631_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/01913129409016278","volume":"18","author":"EA Turbat-Herrera","year":"1994","unstructured":"Turbat-Herrera EA (1994) Beta 2-microglobulin and the kidney: an overview. Ultrastruct Pathol 18(1-2):99\u2013103. https:\/\/doi.org\/10.3109\/01913129409016278","journal-title":"Ultrastruct Pathol"},{"issue":"8807","key":"5631_CR6","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/0140-6736(92)92030-j","volume":"339","author":"AR Lifson","year":"1992","unstructured":"Lifson AR, Hessol NA, Buchbinder SP, O'Malley PM, Barnhart L, Segal M, Katz MH, Holmberg SD (1992) Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infection. Lancet 339(8807):1436\u20131440. https:\/\/doi.org\/10.1016\/0140-6736(92)92030-j","journal-title":"Lancet"},{"issue":"9","key":"5631_CR7","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1136\/jnnp.50.9.1238","volume":"50","author":"JC Alvarez-Cerme\u00f1o","year":"1987","unstructured":"Alvarez-Cerme\u00f1o JC, Villar LM, Roy G, Ferreira A, Bootello A, Gimeno A, Gonz\u00e1lez-Porqu\u00e9 P (1987) Increased beta 2-microglobulin in CSF of multiple sclerosis. J Neurol Neurosurg Psychiatry 50(9):1238. https:\/\/doi.org\/10.1136\/jnnp.50.9.1238","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"5631_CR8","doi-asserted-by":"publisher","first-page":"e22411","DOI":"10.7759\/cureus.22411","volume":"14","author":"E Koumadoraki","year":"2022","unstructured":"Koumadoraki E, Madouros N, Sharif S, Saleem A, Jarvis S, Khan S (2022) Hemophagocytic lymphohistiocytosis and infection: a literature review. Cureus 14(2):e22411. https:\/\/doi.org\/10.7759\/cureus.22411","journal-title":"Cureus"},{"issue":"16","key":"5631_CR9","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1182\/blood.2019000936","volume":"135","author":"SW Canna","year":"2020","unstructured":"Canna SW, Marsh RA (2020) Pediatric hemophagocytic lymphohistiocytosis. Blood 135(16):1332\u20131343. https:\/\/doi.org\/10.1182\/blood.2019000936","journal-title":"Blood"},{"issue":"3","key":"5631_CR10","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1016\/s2352-3026(21)00366-5","volume":"9","author":"A Setiadi","year":"2022","unstructured":"Setiadi A, Zoref-Lorenz A, Lee CY, Jordan MB, Chen LYC (2022) Malignancy-associated haemophagocytic lymphohistiocytosis. Lancet Haematol 9(3):e217\u2013e227. https:\/\/doi.org\/10.1016\/s2352-3026(21)00366-5","journal-title":"Lancet Haematol"},{"issue":"23","key":"5631_CR11","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood.2018894618","volume":"133","author":"P La Ros\u00e9e","year":"2019","unstructured":"La Ros\u00e9e P, Horne A, Hines M, von Bahr GT, Machowicz R, Berliner N, Birndt S, Gil-Herrera J, Girschikofsky M, Jordan MB, Kumar A, van Laar JAM, Lachmann G, Nichols KE, Ramanan AV, Wang Y, Wang Z, Janka G, Henter JI (2019) Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood 133(23):2465\u20132477. https:\/\/doi.org\/10.1182\/blood.2018894618","journal-title":"Blood"},{"issue":"18","key":"5631_CR12","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1002\/cncr.30084","volume":"122","author":"GN Tamamyan","year":"2016","unstructured":"Tamamyan GN, Kantarjian HM, Ning J, Jain P, Sasaki K, McClain KL, Allen CE, Pierce SA, Cortes JE, Ravandi F, Konopleva MY, Garcia-Manero G, Benton CB, Chihara D, Rytting ME, Wang S, Abdelall W, Konoplev SN, Daver NG (2016) Malignancy-associated hemophagocytic lymphohistiocytosis in adults: relation to hemophagocytosis, characteristics, and outcomes. Cancer 122(18):2857\u20132866. https:\/\/doi.org\/10.1002\/cncr.30084","journal-title":"Cancer"},{"issue":"10","key":"5631_CR13","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1111\/apa.15973","volume":"110","author":"S Imashuku","year":"2021","unstructured":"Imashuku S, Morimoto A, Ishii E (2021) Virus-triggered secondary hemophagocytic lymphohistiocytosis. Acta Paediatr 110(10):2729\u20132736. https:\/\/doi.org\/10.1111\/apa.15973","journal-title":"Acta Paediatr"},{"issue":"2","key":"5631_CR14","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1016\/j.clml.2020.10.009","volume":"21","author":"B Li","year":"2021","unstructured":"Li B, Guo J, Li T, Gu J, Zeng C, Xiao M, Zhang W, Li Q, Zhou J, Zhou X (2021) Clinical characteristics of hemophagocytic lymphohistiocytosis associated with non-Hodgkin b-cell lymphoma: a multicenter retrospective study. Clin Lymphoma Myeloma Leuk 21(2):e198\u2013e205. https:\/\/doi.org\/10.1016\/j.clml.2020.10.009","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"10","key":"5631_CR15","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1007\/s00277-022-04953-1","volume":"101","author":"G Meng","year":"2022","unstructured":"Meng G, Wang J, Cui T, Wang Z (2022) Clinical characteristics and treatment of NK\/T-cell lymphoma-associated HLH. Ann Hematol 101(10):2289\u20132296. https:\/\/doi.org\/10.1007\/s00277-022-04953-1","journal-title":"Ann Hematol"},{"issue":"3","key":"5631_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/cm9.0000000000000088","volume":"132","author":"DY Huang","year":"2019","unstructured":"Huang DY, Hu YF, Wei N, Fu L, Wu L, Shen J, Wang JS, Wang Z (2019) Innovative analysis of predictors for overall survival from systemic non-Hodgkin T cell lymphoma using quantile regression analysis. Chin Med J (Engl) 132(3):294\u2013301. https:\/\/doi.org\/10.1097\/cm9.0000000000000088","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"5631_CR17","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.3324\/haematol.2019.220301","volume":"105","author":"JH Liang","year":"2020","unstructured":"Liang JH, Wang L, Zhu HY, Qian J, Liao H, Wu JZ, Xia Y, Wu W, Cao L, Fan L, Li JY, Xu W (2020) Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial. Haematologica 105(1):e29\u2013e32. https:\/\/doi.org\/10.3324\/haematol.2019.220301","journal-title":"Haematologica"},{"issue":"27","key":"5631_CR18","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.1200\/jco.2008.21.3991","volume":"27","author":"M Federico","year":"2009","unstructured":"Federico M, Bellei M, Marcheselli L, Luminari S, Lopez-Guillermo A, Vitolo U, Pro B, Pileri S, Pulsoni A, Soubeyran P, Cortelazzo S, Martinelli G, Martelli M, Rigacci L, Arcaini L, Di Raimondo F, Merli F, Sabattini E, McLaughlin P, Solal-C\u00e9ligny P (2009) Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol 27(27):4555\u20134562. https:\/\/doi.org\/10.1200\/jco.2008.21.3991","journal-title":"J Clin Oncol"},{"issue":"47","key":"5631_CR19","doi-asserted-by":"publisher","first-page":"76934","DOI":"10.18632\/oncotarget.12734","volume":"7","author":"S Seo","year":"2016","unstructured":"Seo S, Hong JY, Yoon S, Yoo C, Park JH, Lee JB, Park CS, Huh J, Lee Y, Kim KW, Ryu JS, Kim SJ, Kim WS, Yoon DH, Suh C (2016) Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era. Oncotarget 7(47):76934\u201376943. https:\/\/doi.org\/10.18632\/oncotarget.12734","journal-title":"Oncotarget"},{"issue":"1","key":"5631_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/hon.2188","volume":"34","author":"C Yoo","year":"2016","unstructured":"Yoo C, Yoon DH, Kim S, Huh J, Park CS, Park CJ, Lee SW, Suh C (2016) Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma. Hematol Oncol 34(1):22\u201327. https:\/\/doi.org\/10.1002\/hon.2188","journal-title":"Hematol Oncol"},{"issue":"6","key":"5631_CR21","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1200\/jco.1993.11.6.1108","volume":"11","author":"MA Dimopoulos","year":"1993","unstructured":"Dimopoulos MA, Cabanillas F, Lee JJ, Swan F, Fuller L, Allen PK, Hagemeister FB (1993) Prognostic role of serum beta 2-microglobulin in Hodgkin\u2019s disease. J Clin Oncol 11(6):1108\u20131111. https:\/\/doi.org\/10.1200\/jco.1993.11.6.1108","journal-title":"J Clin Oncol"},{"issue":"6","key":"5631_CR22","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00277-014-2015-2","volume":"93","author":"C Yoo","year":"2014","unstructured":"Yoo C, Yoon DH, Jo JC, Yoon S, Kim S, Lee BJ, Huh J, Lee SW, Suh C (2014) Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer\/T cell lymphoma. Ann Hematol 93(6):995\u20131000. https:\/\/doi.org\/10.1007\/s00277-014-2015-2","journal-title":"Ann Hematol"},{"issue":"3","key":"5631_CR23","doi-asserted-by":"publisher","first-page":"847","DOI":"10.4143\/crt.2020.1060","volume":"53","author":"HD Kim","year":"2021","unstructured":"Kim HD, Cho H, Kim S, Lee K, Kang EH, Park JS, Park CS, Huh J, Ryu JS, Lee SW, Yoon DH, Kim SJ, Ko YH, Kim WS, Suh C (2021) Prognostic stratification of patients with Burkitt lymphoma using serum \u03b22-microglobulin Levels. Cancer Res Treat 53(3):847\u2013856. https:\/\/doi.org\/10.4143\/crt.2020.1060","journal-title":"Cancer Res Treat"},{"issue":"8","key":"5631_CR24","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1182\/blood-2007-06-094417","volume":"110","author":"J Yang","year":"2007","unstructured":"Yang J, Zhang X, Wang J, Qian J, Zhang L, Wang M, Kwak LW, Yi Q (2007) Anti beta2-microglobulin monoclonal antibodies induce apoptosis in myeloma cells by recruiting MHC class I to and excluding growth and survival cytokine receptors from lipid rafts. Blood 110(8):3028\u20133035. https:\/\/doi.org\/10.1182\/blood-2007-06-094417","journal-title":"Blood"},{"issue":"6","key":"5631_CR25","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1093\/ndt\/16.6.1108","volume":"16","author":"E Balint","year":"2001","unstructured":"Balint E, Sprague SM (2001) Beta(2)-microglobulin and bone cell metabolism. Nephrol Dial Transplant 16(6):1108\u20131111. https:\/\/doi.org\/10.1093\/ndt\/16.6.1108","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"5631_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000045663","volume":"85","author":"CY Tsai","year":"2000","unstructured":"Tsai CY, Wu TH, Yu CL, Lu JY, Tsai YY (2000) Increased excretions of beta2-microglobulin, IL-6, and IL-8 and decreased excretion of Tamm-Horsfall glycoprotein in urine of patients with active lupus nephritis. Nephron 85(3):207\u2013214. https:\/\/doi.org\/10.1159\/000045663","journal-title":"Nephron"},{"issue":"18","key":"5631_CR27","doi-asserted-by":"publisher","first-page":"9108","DOI":"10.1158\/0008-5472.Can-06-1996","volume":"66","author":"WC Huang","year":"2006","unstructured":"Huang WC, Wu D, Xie Z, Zhau HE, Nomura T, Zayzafoon M, Pohl J, Hsieh CL, Weitzmann MN, Farach-Carson MC, Chung LW (2006) Beta2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis. Cancer Res 66(18):9108\u20139116. https:\/\/doi.org\/10.1158\/0008-5472.Can-06-1996","journal-title":"Cancer Res"},{"issue":"24","key":"5631_CR28","doi-asserted-by":"publisher","first-page":"7294","DOI":"10.1158\/1078-0432.Ccr-06-2060","volume":"12","author":"T Nomura","year":"2006","unstructured":"Nomura T, Huang WC, Zhau HE, Wu D, Xie Z, Mimata H, Zayzafoon M, Young AN, Marshall FF, Weitzmann MN, Chung LW (2006) Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axis. Clin Cancer Res 12(24):7294\u20137305. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-06-2060","journal-title":"Clin Cancer Res"},{"issue":"7","key":"5631_CR29","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1158\/0008-5472.Can-10-3382","volume":"71","author":"S Josson","year":"2011","unstructured":"Josson S, Nomura T, Lin JT, Huang WC, Wu D, Zhau HE, Zayzafoon M, Weizmann MN, Gururajan M, Chung LW (2011) \u03b22-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells. Cancer Res 71(7):2600\u20132610. https:\/\/doi.org\/10.1158\/0008-5472.Can-10-3382","journal-title":"Cancer Res"},{"issue":"5","key":"5631_CR30","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/s1471-4906(03)00076-0","volume":"24","author":"J Xie","year":"2003","unstructured":"Xie J, Yi Q (2003) Beta2-microglobulin as a potential initiator of inflammatory responses. Trends Immunol 24(5):228\u2013229; author reply 229-230. https:\/\/doi.org\/10.1016\/s1471-4906(03)00076-0","journal-title":"Trends Immunol"},{"issue":"3","key":"5631_CR31","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s12185-010-0533-9","volume":"91","author":"K Itoh","year":"2010","unstructured":"Itoh K, Kinoshita T, Watanabe T, Yoshimura K, Okamoto R, Chou T, Ogura M, Hirano M, Asaoku H, Kurosawa M, Maeda Y, Omachi K, Moriuchi Y, Kasai M, Ohnishi K, Takayama N, Morishima Y, Tobinai K, Kaba H et al (2010) Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan. Int J Hematol 91(3):446\u2013455. https:\/\/doi.org\/10.1007\/s12185-010-0533-9","journal-title":"Int J Hematol"},{"issue":"3","key":"5631_CR32","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","volume":"95","author":"C Thieblemont","year":"2000","unstructured":"Thieblemont C, Berger F, Dumontet C, Moullet I, Bouafia F, Felman P, Salles G, Coiffier B (2000) Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 95(3):802\u2013806","journal-title":"Blood"},{"issue":"6","key":"5631_CR33","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1053\/j.ajkd.2014.10.012","volume":"65","author":"F Aulagnon","year":"2015","unstructured":"Aulagnon F, Lapidus N, Canet E, Galicier L, Boutboul D, Peraldi MN, Reuter D, Bernard R, Schlemmer B, Azoulay E, Zafrani L (2015) Acute kidney injury in adults with hemophagocytic lymphohistiocytosis. Am J Kidney Dis 65(6):851\u2013859. https:\/\/doi.org\/10.1053\/j.ajkd.2014.10.012","journal-title":"Am J Kidney Dis"},{"issue":"3-4","key":"5631_CR34","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1081\/JDI-100104725","volume":"23","author":"C Bianchi","year":"2001","unstructured":"Bianchi C, Donadio C, Tramonti G, Consani C, Lorusso P, Rossi G (2001) Reappraisal of serum \u03b22-microglobulin as marker of GFR. Renal Failure 23(3-4):419\u2013429","journal-title":"Renal Failure"},{"issue":"3","key":"5631_CR35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2165\/00003088-197904030-00003","volume":"4","author":"TD Bjornsson","year":"1979","unstructured":"Bjornsson TD (1979) Use of serum creatinine concentrations to determine renal function. Clin Pharmacokinet 4(3):200\u2013222. https:\/\/doi.org\/10.2165\/00003088-197904030-00003","journal-title":"Clin Pharmacokinet"},{"key":"5631_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/bs.acc.2014.11.007","volume":"68","author":"A Onopiuk","year":"2015","unstructured":"Onopiuk A, Tokarzewicz A, Gorodkiewicz E (2015) Cystatin C: a kidney function biomarker. Adv Clin Chem 68:57\u201369. https:\/\/doi.org\/10.1016\/bs.acc.2014.11.007","journal-title":"Adv Clin Chem"},{"issue":"4","key":"5631_CR37","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3109\/10428194.2010.551153","volume":"52","author":"M Machaczka","year":"2011","unstructured":"Machaczka M, Vaktn\u00e4s J, Klimkowska M, H\u00e4gglund H (2011) Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center. Leuk Lymphoma 52(4):613\u2013619. https:\/\/doi.org\/10.3109\/10428194.2010.551153","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"5631_CR38","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/bjh.12823","volume":"165","author":"H Sano","year":"2014","unstructured":"Sano H, Kobayashi R, Tanaka J, Hashino S, Ota S, Torimoto Y, Kakinoki Y, Yamamoto S, Kurosawa M, Hatakeyama N, Haseyama Y, Sakai H, Sato K, Fukuhara T (2014) Risk factor analysis of non-Hodgkin lymphoma-associated haemophagocytic syndromes: a multicentre study. Br J Haematol 165(6):786\u2013792. https:\/\/doi.org\/10.1111\/bjh.12823","journal-title":"Br J Haematol"},{"key":"5631_CR39","doi-asserted-by":"publisher","first-page":"882589","DOI":"10.3389\/fimmu.2022.882589","volume":"13","author":"A Zhao","year":"2022","unstructured":"Zhao A, Yang J, Li M, Li L, Gan X, Wang J, Li H, Shen K, Yang Y, Niu T (2022) Epstein-Barr virus-positive lymphoma-associated hemophagocytic syndrome: a retrospective, single-center study of 51 patients. Front Immunol 13:882589. https:\/\/doi.org\/10.3389\/fimmu.2022.882589","journal-title":"Front Immunol"},{"key":"5631_CR40","doi-asserted-by":"publisher","first-page":"788056","DOI":"10.3389\/fonc.2021.788056","volume":"11","author":"S Yao","year":"2021","unstructured":"Yao S, Jin Z, He L, Zhang R, Liu M, Hua Z, Wang Z, Wang Y (2021) Clinical features and prognostic risk prediction of non-Hodgkin lymphoma-associated hemophagocytic syndrome. Front Oncol 11:788056. https:\/\/doi.org\/10.3389\/fonc.2021.788056","journal-title":"Front Oncol"},{"key":"5631_CR41","doi-asserted-by":"publisher","first-page":"704962","DOI":"10.3389\/fonc.2021.704962","volume":"11","author":"N Li","year":"2021","unstructured":"Li N, Jiang M, Wu WC, Wei WW, Zou LQ (2021) How to identify patients at high risk of developing nasal-type, extranodal nature killer\/T-cell lymphoma-associated hemophagocytic syndrome. Front Oncol 11:704962. https:\/\/doi.org\/10.3389\/fonc.2021.704962","journal-title":"Front Oncol"},{"issue":"6","key":"5631_CR42","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1007\/s10875-023-01493-9","volume":"43","author":"J Zhang","year":"2023","unstructured":"Zhang J, Qin S, Jin Z, Chen Q, Xing L, Qiu T, Xia Y, Liang J, Zhu H, Wang L, Fan L, Xu W, Li J, Miao Y (2023) The clinical significance and prognostic role of whole-blood Epstein-Barr virus DNA in lymphoma-associated hemophagocytic lymphohistiocytosis. J Clin Immunol 43(6):1302\u20131310. https:\/\/doi.org\/10.1007\/s10875-023-01493-9","journal-title":"J Clin Immunol"},{"issue":"1","key":"5631_CR43","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13045-016-0317-7","volume":"9","author":"J Wang","year":"2016","unstructured":"Wang J, Wang Y, Wu L, Zhang J, Lai W, Wang Z (2016) PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Hematol Oncol 9(1):84. https:\/\/doi.org\/10.1186\/s13045-016-0317-7","journal-title":"J Hematol Oncol"},{"issue":"3","key":"5631_CR44","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/bjh.16861","volume":"191","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Li Z, Zhang L, Lian H, Ma H, Wang D, Zhao X, Zhang Q, Wang T, Zhang R (2020) L-DEP regimen salvage therapy for paediatric patients with refractory Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis. Br J Haematol 191(3):453\u2013459. https:\/\/doi.org\/10.1111\/bjh.16861","journal-title":"Br J Haematol"},{"issue":"11","key":"5631_CR45","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1182\/blood.2019003886","volume":"135","author":"P Liu","year":"2020","unstructured":"Liu P, Pan X, Chen C, Niu T, Shuai X, Wang J, Chen X, Liu J, Guo Y, Xie L, Wu Y, Liu Y, Liu T (2020) Nivolumab treatment of relapsed\/refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults. Blood 135(11):826\u2013833. https:\/\/doi.org\/10.1182\/blood.2019003886","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05631-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05631-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05631-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T16:03:25Z","timestamp":1720109005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05631-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["5631"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05631-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,25]]},"assertion":[{"value":"20 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Affiliated Hospital of Nantong University. The study was conducted according to the ethical guidelines of the Helsinki Declaration of 1975, as revised in 2008. Patient consent was waived because this was a retrospective and de-identified study. All the laboratory studies did not require specific ethical approval because they were done as part of the routine workup of patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}